相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma
Michelle Fanale et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Epstein-Barr virus maintains lymphomas via its miRNAs
D. T. Vereide et al.
ONCOGENE (2014)
Different Patterns of Epstein-Barr Virus Latency in Endemic Burkitt Lymphoma (BL) Lead to Distinct Variants within the BL-Associated Gene Expression Signature
Gemma L. Kelly et al.
JOURNAL OF VIROLOGY (2013)
Advances in targeting cell surface signalling molecules for immune modulation
Sheng Yao et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
Obinna Chijioke et al.
CELL REPORTS (2013)
The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8
Shuvomoy Banerjee et al.
PLOS PATHOGENS (2013)
Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
Lenka Skalska et al.
PLOS PATHOGENS (2013)
A Novel Monoclonal Antibody to CD40 Prolongs Islet Allograft Survival
M. Lowe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yibin Yang et al.
CANCER CELL (2012)
Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
Baochun Zhang et al.
CELL (2012)
The Latent Membrane Protein 1 (LMP1) Oncogene of Epstein-Barr Virus Can Simultaneously Induce and Inhibit Apoptosis in B Cells
Zachary L. Pratt et al.
JOURNAL OF VIROLOGY (2012)
An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse Model
Shi-Dong Ma et al.
JOURNAL OF VIROLOGY (2012)
B-cell activating factor targeted therapy and lupus
Alexis Boneparth et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Humanized mice for immune system investigation: progress, promise and challenges
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Lymphomas differ in their dependence on Epstein-Barr virus
David T. Vereide et al.
BLOOD (2011)
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma
Lisa Giulino et al.
BLOOD (2011)
A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
Shi-Dong Ma et al.
JOURNAL OF VIROLOGY (2011)
Antigen-Dependent and -Independent Mechanisms of T and B Cell Hyperactivation during Chronic HIV-1 Infection
Anna Haas et al.
JOURNAL OF VIROLOGY (2011)
Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression
Ling Wang et al.
JOURNAL OF VIROLOGY (2011)
IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma
Donatella Aldinucci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
T-cell/histiocyte-rich large B-cell lymphoma
Stefania Pittaluga et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rγnull mice
Deepika Rajesh et al.
HUMAN IMMUNOLOGY (2010)
Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1
John P. Graham et al.
IMMUNOLOGICAL REVIEWS (2010)
CD40 Ligand (CD154) Incorporated into HIV Virions Induces Activation-Induced Cytidine Deaminase (AID) Expression in Human B Lymphocytes
Marta Epeldegui et al.
PLOS ONE (2010)
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
Till Strowig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition
Jill M. Brooks et al.
JOURNAL OF IMMUNOLOGY (2009)
CD34+ Cord Blood Cell-Transplanted Rag2-/- γc-/- Mice as a Model for Epstein-Barr Virus Infection
Mario Cocco et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency IIIB cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis
Christophe Le Clorennec et al.
JOURNAL OF VIROLOGY (2008)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
Human BLyS Facilitates Engraftment of Human PBL Derived B Cells in Immunodeficient Mice
Madelyn R. Schmidt et al.
PLOS ONE (2008)
The LMP1 oncogene of EBV activates PERK and the unfolded protein response to chive its own synthesis
Dong Yun Lee et al.
BLOOD (2008)
LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1
Julia Rastelli et al.
BLOOD (2008)
EBV latent membrane protein 1 activates Akt, NFκB, and Stat3 in B cell lymphomas
Kathy H. Y. Shair et al.
PLOS PATHOGENS (2007)
Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells
Georgina J. MacArthur et al.
JOURNAL OF VIROLOGY (2007)
Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease
A Kasran et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2
LL Kis et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway
T Portis et al.
ONCOGENE (2004)
Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments - A novel approach to screen for the virus in paraffin-embedded tissue and plasma
JL Ryan et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching
B He et al.
JOURNAL OF IMMUNOLOGY (2003)
CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation
KI Imadome et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms
S Prince et al.
JOURNAL OF VIROLOGY (2003)
Primary immune responses by cord blood CD4+ T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro
AD Wilson et al.
JOURNAL OF VIROLOGY (2002)
Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice
I Johannessen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
